Search results for "digestive"

showing 10 items of 2631 documents

Pulmonary function abnormalities in respiratory asymptomatic patients with inflammatory bowel disease

2002

BACKGROUND: There is evidence that pulmonary function abnormalities are present in patients with inflammatory bowel disease (IBD). The aim of this crossover study was to assess the frequency of pulmonary dysfunction in patients with IBD and to define the importance of possible confounding factors. METHODS: We investigated a total of 44 patients with Crohn's disease or ulcerative colitis and no pulmonary symptoms or a history of respiratory diseases by means of pulmonary function testing and chest X-ray. As controls we examined 44 healthy subjects matched for gender, age, and smoking status. RESULTS: A total of 21% of the subjects with ulcerative colitis and 20% with Crohn's disease showed a…

medicine.medical_specialtyCrohn's diseasebusiness.industryDiseasemedicine.diseaseCrossover studyAsymptomaticGastroenterologyUlcerative colitisInflammatory bowel diseasedigestive system diseasesPulmonary function testingInternal medicineInternal MedicineMedicineRespiratory systemmedicine.symptombusinessEuropean Journal of Internal Medicine
researchProduct

P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory bowel disease: the impact of traditional risk factors, inte…

2020

Abstract Background Prevalence of NAFLD has recently been reported increased in inflammatory bowel disease (IBD) with conflicting results due to heterogeneity of published studies, especially in the diagnostic definition of NAFLD. The increased risk of NAFLD might be related to traditional risk factors but also to IBD-related factors. The role of genetic markers has been addressed only in one study. The aim of our study has been to assess the prevalence of NAFLD and fibrosis in a homogeneous cohort of patients with IBD, assessing the role of metabolic, disease-related and genetic factors. Methods the diagnosis of NAFLD was based on transient fibroelastometry findings (CAP ≥288 dB/m) and HSI…

medicine.medical_specialtyCrohn's diseasebusiness.industryFatty liverGastroenterologySingle-nucleotide polymorphismInflammationGeneral MedicineDiseasemedicine.diseaseInflammatory bowel diseaseGastroenterologyUlcerative colitisdigestive system diseasesFibrosisInternal medicinemedicinemedicine.symptombusinessJournal of Crohn's and Colitis
researchProduct

Surgery and Crohn’s Disease

2015

It is known that the treatment of Crohn’s disease (CD) absolutely needs a multidisciplinary approach with an important relationship between gastroenterologist and surgeon. CD, in fact, is a chronic inflammatory bowel disease interesting all segments of alimentary tract showing extreme variability of clinical presentations. Medical therapy when ineffective will give way to surgical treatment, and the last one isn’t possible without adequate pharmacological support. Synthetically, it’s possible to affirm that gastroenterologist treats CD and the surgeon its complications.

medicine.medical_specialtyCrohn's diseasebusiness.industryMedicine (all)medicineDiseaseIleocecal resectionShort bowel syndromemedicine.diseasebusinessdigestive system diseasesSurgery
researchProduct

Clinical Presentation of Crohn’s Disease

2015

Crohn’s disease is an idiopathic chronic inflammatory disease of the gut, which may involve the entire gastrointestinal tract from the mouth to the perianal area, though preferring in most cases the distal small bowel and the proximal large bowel. Its heterogeneous nature is reflected in a number of different phenotypes. Approximately 80 % of patients have small bowel involvement, usually in the distal ileum, with one-third of patients having exclusively ileitis. Approximately 50 % of patients have ileocolitis which refers to involvement of both the ileum and colon. From 20 to 25 % of patients have disease confined to the colon. Involvement of the esophagus, stomach, or duodenum is rare and…

medicine.medical_specialtyCrohn's diseasebusiness.industryStomachdigestive oral and skin physiologyIleummedicine.diseaseShort bowel syndromeGastroenterologydigestive system diseasesPrimary sclerosing cholangitismedicine.anatomical_structureInternal medicineDuodenumMedicineIleitisEsophagusbusiness
researchProduct

Diagnostic Significance of Epithelioid Granulomas in Crohnʼs Disease in Children

1990

Out of 528 children with Crohn's disease in a Multicenter Paediatric Crohn's Disease Study Group, 37 cases had epithelioid granulomas but did not fulfill defined radiographic criteria of the disease. Follow-up studies including clinical, biochemical, radiological, endoscopic, and histological investigations were done in these patients. Initially, all patients showed clinical symptoms and 27 of them had biochemical signs of chronic inflammation. After a mean follow-up of 3 years, all 37 children treated for Crohn's disease got a complete upper gastrointestinal series with small bowel followthrough and 8 children in addition had barium enemas. Colonoscopies were done in 23 patients. Radiograp…

medicine.medical_specialtyCrohn's diseasemedicine.diagnostic_testUpper gastrointestinal seriesbusiness.industryGastroenterologyDiseasemedicine.diseaseDermatologyGastroenterologydigestive system diseasesChronic granulomatous diseaseInternal medicineGranulomaPediatrics Perinatology and Child HealthBiopsymedicinebusinessEpithelioid cellBarium enemaJournal of Pediatric Gastroenterology and Nutrition
researchProduct

Clinical characterization of gingival type of burning mouth syndrome:a cross-sectional study

2021

Background The aim of this study is to investigate the prevalence of localized intraoral neuropathic pain in a cluster of patients who reported the involvement of gingival site as only clinical manifestation of dysesthesia, analysing type and distribution of symptoms. Material and Methods Burning mouth syndrome (BMS) patients were enrolled in the study. Patients were screened through laboratory test and a conventional oral examination with periodontal chart. A questionnaire to collect data on symptoms, oral site involved, quality of sleep, anxiety was submitted to all the patients. Results A total of 236 patients were recruited. Seventy-six patients (32.2%) presented generalized type, where…

medicine.medical_specialtyCross-sectional studyQuality of sleepGingivaBurning Mouth SyndromeClinical manifestationAnxietymedicineHumansGeneral DentistryUNESCO:CIENCIAS MÉDICAStooth extractionOral Medicine and PathologyDysesthesiabusiness.industryResearchdigestive oral and skin physiologyBurning mouth syndromeAnxiety DisordersDermatologypostoperative caresupernumerary toothpediatric dentistrystomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologyNeuropathic painOral examinationAnxietyoral healthSurgerymedicine.symptombusiness
researchProduct

Breath test using 13C methacetin does not seem to be useful in the assessment of liver function in girls with anorexia nervosa: a case control study

2018

Abstract Background Anorexia nervosa (AN) concerns approximately up to 1.8% of the pediatric female population. One of the complications that can occur in the course of this disease is acute liver failure. This study’s objective was to assess the usefulness of the 13C labeled Methacetin Breath Test (MBT) in the diagnostics of the liver function in girls with eating disorders. Methods For the study 81 girls aged 12 to 17 years were recruited, including 41 patients with confirmed diagnosis of AN (mean age 14.7 ± 1.48 years) and 40 age-matched controls. The diagnosis was based on the present Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria. Weight and height were measured…

medicine.medical_specialtyCytochrome P450AnorexiaLiver functionGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicinelcsh:RC799-869Breath testmedicine.diagnostic_testCumulative dosebusiness.industryGastroenterologyMethacetin breath testAnorexia nervosaGeneral MedicineHepatologymedicine.diseaseEating disordersAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesislcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyLiver functionmedicine.symptombusinessBody mass indexBMC Gastroenterology
researchProduct

The Use of a Nonimmersive Virtual Reality Programme in Anorexia Nervosa: A Single Case-Report

2011

Objective: People with anorexia nervosa (AN) experience high levels of fear and anxiety related to eating. The aim of this case report was to describe the use of a virtual reality (VR) programme developed to facilitate exposure to food as a supplement to treatment for a person with AN. Method: A 21-year-old patient with AN was given the VR module in addition to the Maudsley Model of Treatment for Adults with Anorexia Nervosa. Weight, eating disorder symptomatology (EDE-Q) and general psychopathology (DASS) were assessed before and after the module was delivered. Results: At the end of the module, the patient reported lower levels of anxiety, safety behaviours and fears related to food. Both…

medicine.medical_specialtyDASSdigestive oral and skin physiologymedicine.diseasePsychiatry and Mental healthClinical PsychologyDistressEating disordersAnorexia nervosa (differential diagnoses)Severity of illnessmedicineAnxietyYoung adultmedicine.symptomPsychologyPsychiatryBody mass indexClinical psychologyEuropean Eating Disorders Review
researchProduct

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic h…

2015

Summary Background Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global HCV infections. Because interferon-containing treatments for genotype 4 infection have low efficacy and poor tolerability, an unmet need exists for effective all-oral regimens. We examined the efficacy and safety of an all-oral interferon-free regimen of ombitasvir, an NS5A inhibitor, and paritaprevir (ABT-450), an NS3/4A protease inhibitor dosed with ritonavir (ombitasvir plus paritaprevir plus ritonavir), given with or without ribavirin. Methods In this multicentre ongoing phase 2b, randomised, open-label combination trial (PEARL-I), patients were recruited from academic, public, and private hospitals a…

medicine.medical_specialtyDasabuvirbusiness.industryRibavirinvirus diseasesGeneral MedicinePharmacologydigestive system diseasesOmbitasvirchemistry.chemical_compoundRegimenchemistryTolerabilityParitaprevirInternal medicineOmbitasvir/paritaprevir/ritonavirmedicineRitonavirbusinessmedicine.drugThe Lancet
researchProduct

Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support

2012

The target of this paper is to describe the use of fuzzy techniques in the development of a decision support system that allows the optimization of postprandial glycemia in type 1 diabetes patients taking into account the kind of meal taken by patients, the preprandial glycemia and the insulin resistance (the response of the body to insulin dose injection therapy). The decision support system can, in many cases, provide patients with the correct number of rapid insulin units that must be assumed to assure an optimal glycemic profile, keeping the blood glucose level close to the homeostatic condition, several hours after the meal.

medicine.medical_specialtyDecision support systemType 1 diabetesAdaptive neuro fuzzy inference systembusiness.industryInsulinmedicine.medical_treatmentdigestive oral and skin physiologyGeneral Engineeringmedicine.diseaseFuzzy logicComputer Science ApplicationsInsulin resistancePostprandialArtificial IntelligencemedicineIntensive care medicinebusinessGlycemicExpert Systems with Applications
researchProduct